Since the start of 2012, at least 19 funds with a focus on life science investing in Europe have raised a total of more than $2.5 billion. (A) Fund was closed in 2010, but was re-opened to accept new and increased commitments; (B) Raised in 2012 from retail investors; (C) Plans to